aldosterone has been researched along with drospirenone in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bähr, V; Beier, S; Berger, V; Bolik, A; Elger, W; Hazard, B; Heithecker, A; Oelkers, W | 1 |
| Buse, M; Casals-Stenzel, J; Losert, W | 1 |
| Dombrovicz, N; Foidart, JM; Heithecker, R; Oelkers, W; Welter, A | 1 |
| Oelkers, WK | 1 |
| Heithecker, R; Helmerhorst, FM; Oelkers, W; Wuttke, W | 1 |
| Alonso, A; Karara, AH; Panzitta, D; Preston, RA; Zhang, P | 1 |
| Chauhan, V; Hanes, V; Pitt, B; White, WB | 1 |
| Arias-Loza, PA; Bauersachs, J; Ertl, G; Fritzemeier, KH; Galle, J; Hegele-Hartung, C; Hu, K; Jazbutyte, V; Neyses, L; Pelzer, T; Quaschning, T; Schäfer, A | 1 |
| Baldacci, C; Caruso, A; Flamini, MI; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Mannella, P; Sanchez, AM; Simoncini, T | 1 |
| Alonso, A; Blode, H; Hanes, V; Karara, AH; Ni, P; Poola, N; Preston, RA; Silang, R | 1 |
| Corrocher, R; Olivieri, O; Pavan, C; Pizzolo, F | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Arias-Loza, PA; Blode, H; Elmore, SA; Ertl, G; Fritzemeier, KH; Hegele-Hartung, C; Hu, K; Maronpot, R; Muehlfelder, M; Pelzer, T | 1 |
| Boschitsch, E; Magometschnigg, D; Mayerhofer, S | 1 |
| Ahmed, AH; Gordon, RD; Pimenta, E; Stowasser, M; Taylor, PJ; Ward, G | 1 |
| Horváth, D; Kovács, GL; Lőcsei, Z; Rácz, K; Szabolcs, I; Toldy, E | 1 |
| Antelmi, A; Armani, A; Canese, R; Caprio, M; Carpinelli, G; Cinti, F; Cinti, S; Cranston, GA; Fabbri, A; Malorni, W; Marconi, M; Marzolla, V; Matarrese, P; Morgan, J; Pagotto, U; Quarta, C; Rosano, G; Young, MJ | 1 |
| Baracat, E; Consolim-Colombo, FM; de Morais, TL; Giribela, C; Guerra, G; Mello, N; Nisenbaum, MG | 1 |
| Baracat, EC; Consolim-Colombo, FM; Giribela, AH; Giribela, CR; Melo, NR; Moraes, TL; Nisenbaum, MG | 1 |
| Channar, PA; El-Seedi, H; Faisal, M; Larik, FA; Mehfooz, H; Saeed, A; Shahzad, D | 1 |
| Archer, DF; Jacot, T; Sabouni, R | 1 |
| Cavalier, E; Dufour, P; Le Goff, C; Vroonen, L | 1 |
3 review(s) available for aldosterone and drospirenone
| Article | Year |
|---|---|
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure.
Topics: Aldosterone; Androstenes; Angiotensinogen; Animals; Blood Pressure; Contraceptives, Oral; Estrogens; Female; Humans; Mineralocorticoid Receptor Antagonists; Postmenopause; Pregnancy; Progesterone; Progestins; Rats; Renin | 1996 |
Hypertension in women: the role of progesterone and aldosterone.
Topics: Aged; Aldosterone; Androstenes; Animals; Cardiovascular Diseases; Diet, Sodium-Restricted; Estradiol; Estrogens; Female; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuresis; Progesterone; Progesterone Congeners; Renin-Angiotensin System; Risk Factors; Sex Characteristics | 2010 |
Synthetic approaches towards the multi target drug spironolactone and its potent analogues/derivatives.
Topics: Aldosterone; Androstadienes; Androstenes; Animals; Canrenone; Chloranil; Dehydroepiandrosterone; Eplerenone; Humans; Molecular Structure; Receptors, Mineralocorticoid; Spironolactone | 2017 |
7 trial(s) available for aldosterone and drospirenone
| Article | Year |
|---|---|
Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
Topics: Adult; Aldosterone; Androstenes; Female; Humans; Mineralocorticoids; Ovulation; Potassium; Renin; Renin-Angiotensin System; Sodium | 1991 |
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Topics: Adolescent; Adult; Aldosterone; Androstenes; Angiotensin I; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Lipids; Mineralocorticoids; Renin; Renin-Angiotensin System | 1995 |
Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
Topics: Adolescent; Adult; Aldosterone; Androstenes; Angiotensinogen; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System | 2000 |
Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril.
Topics: Aldosterone; Androstenes; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Enalapril; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Treatment Outcome | 2002 |
Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.
Topics: Aged; Aldosterone; Androstenes; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Hypertension; Middle Aged; Postmenopause; Potassium; Treatment Outcome | 2006 |
Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
Topics: Aged; Aldosterone; Androstenes; Antihypertensive Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Potassium | 2007 |
Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age.
Topics: Adult; Aldosterone; Androstenes; Antihypertensive Agents; Baroreflex; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Electrolytes; Ethinyl Estradiol; Female; Heart Rate; Homeostasis; Humans; Hypertension; Prospective Studies; Triglycerides; Young Adult | 2014 |
12 other study(ies) available for aldosterone and drospirenone
| Article | Year |
|---|---|
Progestogens with antimineralocorticoid activity.
Topics: Adrenalectomy; Aldosterone; Androstadienes; Androstenes; Animals; Canrenoic Acid; Canrenone; Cyproterone; Dose-Response Relationship, Drug; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Norethindrone; Norgestrel; Norpregnenes; Potassium; Progesterone; Progesterone Congeners; Rats; Rats, Inbred Strains; Sodium; Spironolactone | 1985 |
Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats.
Topics: Aldosterone; Androstenes; Animals; Cardiomegaly; Cardiovascular System; Collagen; Estradiol; Estrogen Antagonists; Female; Medroxyprogesterone Acetate; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Rats; Rats, Wistar; Salts | 2006 |
Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors.
Topics: Aldosterone; Androstadienes; Androstenes; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Estradiol; Flavonoids; Humans; Medroxyprogesterone Acetate; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type III; Progesterone; Receptors, Mineralocorticoid; Receptors, Progesterone; Signal Transduction; Time Factors; Wortmannin | 2007 |
Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy.
Topics: Adult; Aldosterone; Androstenes; Contraceptives, Oral, Hormonal; Contraindications; Ethinyl Estradiol; False Positive Reactions; Female; Humans; Hyperaldosteronism; Renin | 2007 |
Effects of drospirenone on cardiovascular markers in human aortic endothelial cells.
Topics: Adolescent; Aldosterone; Androstenes; Aorta; Biomarkers; Cardiotonic Agents; Cardiovascular System; Cells, Cultured; Chemokine CCL2; Coronary Vessels; E-Selectin; Endothelial Cells; Female; Humans; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Progesterone; Progesterone Congeners; Promegestone; Spironolactone | 2009 |
Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease.
Topics: Aldosterone; Androstenes; Animals; Blood Pressure; Epithelial Sodium Channels; Estradiol; Female; Hypertrophy; Kidney; Kidney Diseases; Medroxyprogesterone Acetate; Oxidative Stress; Progesterone Congeners; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Cytoplasmic and Nuclear; Sodium Chloride; Spironolactone | 2009 |
Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration.
Topics: Adult; Aldosterone; Androstenes; Blood Pressure; Chromatography, High Pressure Liquid; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Immunoassay; Luteinizing Hormone; Progesterone; Renin; Reproductive Control Agents; Tandem Mass Spectrometry | 2011 |
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio.
Topics: Adult; Aldosterone; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progestins; Renin; Renin-Angiotensin System; Young Adult | 2012 |
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adipose Tissue, White; Aldosterone; Androstenes; Animals; Autophagy; Body Composition; Cell Transdifferentiation; Cells, Cultured; Diet, High-Fat; Female; Gene Expression Profiling; Glucose Intolerance; Inguinal Canal; Intra-Abdominal Fat; Ion Channels; Macrolides; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Mitochondrial Proteins; Obesity; Receptors, Mineralocorticoid; Spironolactone; Uncoupling Protein 1; Up-Regulation; Weight Gain | 2014 |
Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
Topics: Adult; Aldosterone; Androstenedione; Androstenes; Blood Pressure; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Insulin Resistance; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Testosterone; Triglycerides | 2015 |
Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells.
Topics: Aldosterone; Androgen Antagonists; Androstenes; Cell Line; Endometrium; Endothelial Cells; Female; Flutamide; Humans; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Receptors, Mineralocorticoid; Tissue Plasminogen Activator | 2021 |
Inconsistencies in laboratory investigations of hypertension in a young woman taking ethinylestradiol/drospirenone association.
Topics: Adult; Aldosterone; Female; Humans; Hypertension; Renin | 2023 |